Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...
The FDA has approved Signos, an AI-powered app that uses continuous glucose monitoring to guide weight loss and personalized nutrition. Cheaper than GLP-1 drugs, Signos offers real-time feedback on ...
Signos, maker of an over-the-counter glucose monitoring system for weight management, announced it secured $20 million in funding and a partnership with continuous glucose monitoring company Dexcom.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results